Stocking, Jacqueline C. http://orcid.org/0000-0003-0775-684X
Drake, Christiana
Aldrich, J. Matthew
Ong, Michael K.
Amin, Alpesh
Marmor, Rebecca A.
Godat, Laura
Cannesson, Maxime
Gropper, Michael A.
Romano, Patrick S.
Sandrock, Christian
Bime, Christian
Abraham, Ivo
Utter, Garth H.
Funding for this research was provided by:
university of california, davis (UL1 TR000002)
american association of critical-care nurses (20297)
national heart, lung, and blood institute (A21-3192)
Article History
Received: 17 August 2021
Accepted: 27 April 2022
First Online: 14 May 2022
Declarations
:
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRBs) of the University of the University of California, Davis (lead site) and Irvine, Los Angeles, San Diego, and San Francisco (collaborating sites) approved this study (IRB #822917; IRB Reliance #1735). All IRBs waived the requirement for informed consent for participation in the study.
: Not applicable.
: Alpesh Amin, MD reported serving as PI or co-I of clinical trials sponsored by NIH/NIAID, NeuroRx Pharma, Pulmotect, Blade Therapeutics, Novartis, Takeda, Humanigen, Eli Lilly, PTC Therapeutics, OctaPharma, Fulcrum Therapeutics, Alexion, unrelated to the present study. He has served as speaker and/or consultant for BMS, Pfizer, BI, Portola, Sunovion, Mylan, Salix, Alexion, AstraZeneca, Novartis, Nabriva, Paratek, Bayer, Tetraphase, Achogen LaJolla, Ferring, Seres, Millenium, PeraHealth, HeartRite, Aseptiscope, Sprightly, unrelated to the present study.Maxime Cannesson, MD has an ownership interest in Sironis, a company developing closed-loop systems and serves as a consultant and receives research support from Edwards Lifesciences (Irvine, CA) and Masimo Corp. (Irvine, CA).Ivo Abraham, PhD is joint equity owner in Matrix45. By company policy, owners and employees are prohibited from owning equity in client and sponsor organizations (except through mutual funds or other independently administered collective investment instruments), contracting independently with client and sponsor organizations, or receive compensation independently from such organizations. Matrix45 provides similar services to other biopharmaceutical, diagnostics, and medical device companies on a non-exclusivity basis. Of relevance to this paper, Matrix45 has not provided any services to this study, and Ivo Abraham’s participation was as a faculty member at the University of Arizona. Abraham is the Quantitative Methods Editor of <i>JAMA Dermatology,</i> for which he receives compensation. He is Deputy Editor-in-Chief of the <i>Journal of Medical Economics</i> for which he receives no compensation but is given an allotment of submissions free of publication charges.